ChrysCapital, Capital Group sell 7.6 percent stake in Mankind Pharma for Rs 5589 crore Ruchika Sharma13 Dec 2023 2:30 PM ISTNew Delhi: ChrysCapital and Capital Group has divested a total of 7.6 per cent stake in pharmaceutical company Mankind Pharma for Rs 5,589 crore...
Glenmark Pharma to divest 75 percent stake in Glenmark Life Sciences to Nirma for Rs 5651 crore Ruchika Sharma22 Sept 2023 11:54 AM IST"Glenmark Pharma will continue to focus on consistent growth across its key markets whilst having a strong emphasis on return ratios with net cash...
Mulling to divest 2 pharma units: Mansukh Mandaviya Roshni Dhar26 Jun 2023 3:25 PM ISTUnion Health Minister Mansukh Mandaviya on Friday said the government is mulling divesting a stake in up to two public sector units engaged in the...
CDPQ divests 0.89 percent stake in Piramal Pharma for Rs 100 crore Ruchika Sharma17 Jun 2023 1:30 PM ISTVanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not...
Ajanta Pharma Promoter entities sell 4.3 percent stake for Rs 637 crore Ruchika Sharma24 Dec 2022 10:00 AM ISTNew Delhi: Promoter entities of Ajanta Pharma has divested 4.3 percent stake in the company for Rs 637 crore through open market transactions. The...
Hinduja Global Solutions to divest healthcare services business to Baring Private Equity Asia Ruchika Sharma11 Aug 2021 10:00 AM ISTNew Delhi: Hinduja Group company Hinduja Global Solutions Ltd (HGS) will divest its healthcare services business to funds affiliated with Baring...
Takeda concludes sale of Select OTC, Non-Core Assets to Hypera Pharma Ruchika Sharma1 Feb 2021 1:23 PM ISTTakeda intends to use the proceeds from the sale to reduce its debt and accelerate deleveraging towards its target of 2x net debt/adjusted EBITDA...
AstraZeneca completes divestment of heart failure, hypertension brand Atacand to Cheplapharm Ruchika Sharma6 Jan 2021 12:59 PM ISTNew Delhi: AstraZeneca has recently announced that the company has completed the divestment of commercial rights to Atacand (candesartan cilexetil)...
